James Investment Research Inc Merck & Co., Inc. Transaction History

James Investment Research Inc

$853 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$102.94 - $114.86 $2,676 - $2,986	26 Added 4.05%	668 $71,000
Q4 2022 Jan 30, 2023	BUY	$87.44 - $112.11 $56,136 - $71,974	642 New	642 $71,000
Q4 2021 Jan 28, 2022	SELL	$72.28 - $90.54 $72,280 - $90,540	-1,000 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$71.68 - $78.83 $398,110 - $437,821	-5,554 Reduced 84.74%	1,000 $75,000
Q2 2021 Jul 26, 2021	SELL	$70.31 - $77.77 $8,859 - $9,799	-126 Reduced 1.89%	6,554 $510,000
Q1 2021 Apr 22, 2021	SELL	$68.86 - $81.11 $1.85 Million - $2.18 Million	-26,879 Reduced 80.09%	6,680 $491,000
Q4 2020 Jan 27, 2021	SELL	$71.77 - $79.65 $211,577 - $234,808	-2,948 Reduced 8.08%	33,559 $2.75 Million
Q3 2020 Oct 23, 2020	SELL	$73.18 - $82.95 $1.42 Million - $1.61 Million	-19,374 Reduced 34.67%	36,507 $3.03 Million
Q2 2020 Jul 24, 2020	SELL	$70.42 - $80.13 $1.98 Million - $2.26 Million	-28,149 Reduced 33.5%	55,881 $4.12 Million
Q1 2020 Apr 22, 2020	SELL	$63.36 - $87.82 $709,188 - $982,969	-11,193 Reduced 11.75%	84,030 $6.17 Million
Q4 2019 Jan 24, 2020	BUY	$77.58 - $87.54 $808,538 - $912,341	10,422 Added 12.29%	95,223 $8.66 Million
Q3 2019 Oct 30, 2019	SELL	$76.08 - $82.93 $319,231 - $347,974	-4,196 Reduced 4.71%	84,801 $6.81 Million
Q2 2019 Jul 24, 2019	BUY	$69.84 - $81.59 $2.06 Million - $2.4 Million	29,467 Added 49.5%	88,997 $7.46 Million
Q1 2019 Apr 26, 2019	SELL	$69.58 - $79.36 $122,530 - $139,752	-1,761 Reduced 2.87%	59,530 $4.95 Million
Q4 2018 Jan 22, 2019	BUY	$65.24 - $75.71 $881,196 - $1.02 Million	13,507 Added 28.27%	61,291 $4.68 Million
Q3 2018 Oct 26, 2018	BUY	$57.69 - $67.84 $117,168 - $137,783	2,031 Added 4.44%	47,784 $3.39 Million
Q2 2018 Jul 19, 2018	SELL	$50.83 - $59.72 $32,582 - $38,280	-641 Reduced 1.38%	45,753 $2.78 Million
Q1 2018 Apr 12, 2018	SELL	$50.96 - $59.23 $338,017 - $392,872	-6,633 Reduced 12.51%	46,394 $2.53 Million
Q4 2017 Jan 23, 2018	SELL	$51.62 - $61.64 $10.4 Million - $12.4 Million	-201,318 Reduced 79.15%	53,027 $2.98 Million
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $14.9 Million - $16.1 Million	254,345	254,345 $16.3 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account